EyePoint (EYPT) Stock Price, Quote, News & History | Benzinga

SPY777.84−0.09%QQQ745.89−0.72%BTC/USD82,654.13−1.23%DIA517.68+0.30%GLD381.86−0.71%TLT77.99+0.01%

EyePoint Inc (EYPT) Stock Price, Quote, News & History

EYPTNASDAQ

Trade with Public

Trade with Public

$3.29

-0.10-3.09%

Last update: Oct 12, 3:43 PM

$3.36

-0.0392-1.15%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$3.42

Close

-

Volume / Avg.

1.00M / 3.90M

Day Range

$3.30 - $3.30

52 Wk Range

3.05 - 19.11

Market Cap

$293.12M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

33

Short Interest

25.38%

Days to Cover

5.38

Recent EyePoint Inc News

Xenon Pharmaceuticals, Steel Dynamics, Nucor And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. futures rise, but Xenon plunges 27.6% after pausing psychiatry trial enrollment over neuropsychiatric adverse events; other stocks also fall

Avi Kapoor

This Toast Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Wednesday

Wall Street analysts changed outlook on top companies. Check out complete rating changes, including upgrades/downgrades, on our page.

Avi Kapoor

Nayax, Immatics, Moderna, Marvell Technology And Other Big Stocks Moving Higher On Tuesday

Nasdaq: NYAX rose 13.9% on Tuesday after announcing acquisition of IPS Group Inc. for $350 million. Other big gainers include CAPR, RZLV, CRML, and MAIR.

Avi Kapoor

These Analysts Slash Their Forecasts On EyePoint

EYPT releases topline results from Phase 3 LUGANO trial for wet AMD treatment. While primary endpoint was not met, secondary endpoints showed progress. Analysts adjust price targets.

Avi Kapoor

Nike, Meta Platforms, INVO Fertility, EyePoint Pharmaceuticals, and Micron: Why These 5 Stocks Are on Investors' Radars Today

Major U.S. indices ended lower on Monday, with the Dow Jones Industrial Average falling 0.51% to 53,459.78

Shivdeep Dhaliwal

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-267.30M

Investing Cash Flow (TTM)

114.88M

Financing Cash Flow (TTM)

191.74M

Free Cash Flow (TTM)

-271.28M

Capital Expenditure (TTM)

-3.98M

Net Change in Cash (TTM)

39.32M

Analyst Trends and Forecast

1

May

1

Jun

3

Jul

6

3

Aug

0

0

0

0

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.4

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$132.46M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

99.35

PB Ratio (TTM)

1.76

Earnings Yield % (TTM)

-110.29%

Earnings Yield % (FWD)

-98.68%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.93

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$111.00K

Total Cash

$110.46M

Debt to Equity

0.12

Issuance of Debt (TTM)

-$111.00K

Repayment of Debt (TTM)

-$111.00K